您的位置: 首页 > 农业专利 > 详情页

Substituted tricyclic compounds as inhibitors of Fibroblast Growth Factor receptor (FGFR). (Divisional Application 3355 - 2014)
专利权人:
INCYTE CORPORATION
发明人:
YAO WENQING,ZHUO JINCONG,HE CHUNHONG,SUN YAPING,LU LIANG,WU LIANGXING,XU MEIZHONG,QIAN DING-QUAN,ZHANG COLIN,ZHANG
申请号:
CL2017001984
公开号:
CL2017001984A1
申请日:
2017.08.03
申请国别(地区):
CL
年份:
2018
代理人:
摘要:
<; p >; The present Invention relates to compounds of the formula I and tricyclic, Pharmaceutical compositions of the sameThey are inhibitors of one or more Enzymes of FGFR and are useful in the treatment of diseases such as cancer associated with FGFR,In which the Radicals are as described in the claims. <; / p >;LA SOLICITUD SE REFIERE A COMPUESTOS DERIVADOS DE TETRAHIDROPIRROLO[2,3-C]NAFTIRIDIONA Y TETRAHIDROIMIDAZO[4,5-H]NAFTIRIDIONA, INHIBIDORES FGFR, A UNA COMPOSICIÓN FARMACÉUTICA QUE LOS COMPRENDE Y A SU USO EN EL TRATAMIENTO DEL CÁNCER.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充